01363nas a2200133   4500008004100000245006500041210006500106260000800171300000800179490000700187520093200194100001701126856008601143       2019                        eng d00aDisruptive innovation at the interfaces of the drug industry0 aDisruptive innovation at the interfaces of the drug industry  cJAN  a5-60 v563 aDr V. Premnath is currently the Head, NCL Innovations – the group within National Chemical Laboratory (NCL) charged with the responsibility of championing the cause of technology innovation within NCL. Dr Premnath is also the Director of the Venture Center – a technology business incubator on the NCL campus. Dr Premnath is also a Scientist, Polymer Science & Engineering Division at NCL with an interest in technology development for medical products.
Dr. V. Premnath holds a B.Tech. from the Indian Institute of Technology - Bombay and a Ph.D. from the Massachusetts Institute of Technology, USA. He has also been a Chevening Technology Enterprise Fellow with the Centre for Scientific Enterprises, London Business School and Cambridge University, UK. Dr Premnath’s experience with medical products development is focused on polymeric implants and has resulted in two families of commercial products and two startups.1 aPremnath, V.  uhttps://library.ncl.res.in/content/disruptive-innovation-interfaces-drug-industry